Hepatocellular carcinoma is often an aggressive tumour and, if unresectable, carries a poor prognosis, especially in the presence of jaundice. We report on a jaundiced patient with an unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin (Adriamycin). The initial response of the patient has been encouraging. This form of therapy deserves further evaluation in patients with unresectable hepatocellular carcinoma.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
hepatocellular carcinoma
16
unresectable fibrolamellar
8
fibrolamellar hepatocellular
8
carcinoma treated
8
treated intra-arterial
8
intra-arterial lipiodolised
8
lipiodolised doxorubicin
8
unresectable
4
hepatocellular
4
carcinoma
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!